DXI Capital Corp. , V.V.T. Med Ltd. and Exiteam Acquisition Corp. are pleased to announce that the TSX Venture Exchange has conditionally approved the previously announced reverse take-over transaction of DXI by VVT and EAC, as outlined in its press releases dated November 28, 2024, October 1, 2024 and November 24, 2023 . The resulting company [...]
DXI Capital is pleased to provide an update on its proposed acquisition of V.V.T. Med Ltd. and Exiteam Acquisition, as outlined in its press release dated Sept 30, 2024. The Company announces that its fulsome initial submission regarding this Proposed Transaction has now been submitted to the TSX-V for review and comment. Subject to the [...]
DXI Capital is pleased to announce that it has entered into a non-binding letter of intent dated Nov 22, 2023 with V.V.T. Med Ltd., an Israeli corporation, and Exiteam Acquisition Corp., pursuant to which DXI has agreed to acquire all of the issued and outstanding shares in the capital of VVT and EAC, as well as all other issued securities of VVT [...]
DXI Capital is pleased to announce the results of its annual general meeting of shareholders held on Thursday May 19, 2022, in Vancouver. AGM Results: The nominees listed in the management information circular, which was mailed to DXI Capital shareholders of record as of March 30, 2022, were elected to the board of directors of the Company to hold [...]
DXI Capital files on Sedar its YE 2020 annual audited financial statements. The Company is now well positioned to source and support a qualifying transaction to leverage DXI Capital's network and lineague in the North American public markets. The Company is actively seeking an impactful tailwind business with a strong, well capitalized management [...]
DXI Capital is pleased to announce that Mr. Sean Hodgins, CPA-CA, CPA has joined DXI as Chief Financial Officer and Chief Operating Officer, and engaged the services of Tandem Innovation Group Inc. to assist in the search for a suitable business transaction. Mr. Hodgins is a veteran of the high tech and life sciences industries with over 20 years [...]
DXI Capital Corp. , further to the Company's news release dated October 23, 2020, the Company announces that it has issued 100,153 shares at a deemed price of $0.475 per share to settle a total of $47,572.68 in debt owed to various creditors. The shares are subject to a statutory hold period expiring on March 20, 2021. The remaining balance of [...]
DXI Capital Corp. , further to the Company's news release dated September 29, 2020, the Company announces that it has issued 8,980,638 shares at a deemed price of $0.475 per share to settle a total of $4,265,803.05 in debt owed to various creditors. The shares are subject to a statutory hold period expiring on February 23, 2021. A remaining amount [...]
DXI Capital Corp. , has arranged a debt settlement of $4,482,426.77 in debt owed to various creditors . The Debts include the amount of $2,057,939.89 owing to Hodgkinson Equities Corp. , a private company owned by Robert Hodgkinson, the CEO and a director of the Company, and $2,057,939.89 owing to Hodgkinson Ventures Inc. , a private company owned [...]
DXI Energy Inc. announces that the name change to "DXI Capital Corp.", and consolidation of its common share capital, on the basis of one hundred issued common shares for one new common share, will be effective following the close of trading on September 10, 2020. No fractional shares are to be issued and any fraction will be reduced to the nearest [...]
DXI Energy Inc. , further to the Company's announcement on April 7, 2020 to discontinue operations in the oil and gas exploration and development industry, the Company received a notice of demand from Hodgkinson Ventures Inc. for repayment of the Company's indebtedness to HVI pursuant to the terms of an Amended and Restated Loan Agreement dated as [...]
DXI Energy Inc. today announced the results of its Annual General and Special Meeting of Shareholders held on August 20, 2020 at the Company's Vancouver office. The following sets forth a brief description of each matter which was voted upon at the Meeting and the outcome of the vote: Description of Matter Outcome of Vote Votes For Votes Against [...]